Carregant...
Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
BACKGROUND: Mucopolysaccharidosis II, also known as Hunter syndrome, is a rare, X‐linked disease caused by a deficiency of the lysosomal enzyme iduronate‐2‐sulfatase, which catalyses a step in the catabolism of glycosaminoglycans. The glycosaminoglycans accumulate within tissues affecting multiple o...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2016
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173756/ https://ncbi.nlm.nih.gov/pubmed/26845288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008185.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|